These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 19879926)
1. Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease. Asuni AA; Hilton K; Siskova Z; Lunnon K; Reynolds R; Perry VH; O'Connor V Neuroscience; 2010 Feb; 165(3):662-74. PubMed ID: 19879926 [TBL] [Abstract][Full Text] [Related]
2. An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease. Chiti Z; Knutsen OM; Betmouni S; Greene JR Neurobiol Dis; 2006 May; 22(2):363-73. PubMed ID: 16431123 [TBL] [Abstract][Full Text] [Related]
3. Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Cunningham C; Deacon RM; Chan K; Boche D; Rawlins JN; Perry VH Neurobiol Dis; 2005 Mar; 18(2):258-69. PubMed ID: 15686954 [TBL] [Abstract][Full Text] [Related]
4. Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. Jeffrey M; Martin S; Barr J; Chong A; Fraser JR J Comp Pathol; 2001 Jan; 124(1):20-8. PubMed ID: 11428185 [TBL] [Abstract][Full Text] [Related]
5. Loss of Perineuronal Net in ME7 Prion Disease. Franklin SL; Love S; Greene JR; Betmouni S J Neuropathol Exp Neurol; 2008 Mar; 67(3):189-99. PubMed ID: 18344910 [TBL] [Abstract][Full Text] [Related]
6. Differences in extinction of conditioned fear in C57BL/6 substrains are unrelated to expression of alpha-synuclein. Siegmund A; Langnaese K; Wotjak CT Behav Brain Res; 2005 Feb; 157(2):291-8. PubMed ID: 15639180 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987 [TBL] [Abstract][Full Text] [Related]
9. MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease. Felton LM; Cunningham C; Rankine EL; Waters S; Boche D; Perry VH Neurobiol Dis; 2005 Nov; 20(2):283-95. PubMed ID: 15886005 [TBL] [Abstract][Full Text] [Related]
10. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175 [TBL] [Abstract][Full Text] [Related]
11. Abnormal synaptic protein expression and cell death in murine scrapie. Sisó S; Puig B; Varea R; Vidal E; Acín C; Prinz M; Montrasio F; Badiola J; Aguzzi A; Pumarola M; Ferrer I Acta Neuropathol; 2002 Jun; 103(6):615-26. PubMed ID: 12012094 [TBL] [Abstract][Full Text] [Related]
12. Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease. Asuni AA; Perry VH; O'Connor V Biochem Soc Trans; 2010 Apr; 38(2):545-51. PubMed ID: 20298219 [TBL] [Abstract][Full Text] [Related]
13. Neuropil and neuronal changes in hippocampal NADPH-diaphorase histochemistry in the ME7 model of murine prion disease. Picanço-Diniz CW; Boche D; Gomes-Leal W; Perry VH; Cunningham C Neuropathol Appl Neurobiol; 2004 Jun; 30(3):292-303. PubMed ID: 15175082 [TBL] [Abstract][Full Text] [Related]
14. Re-transmissibility of mouse-adapted ME7 scrapie strain to ovine PrP transgenic mice. Babalola JA; Kim JM; Lee YJ; Park JH; Choi HS; Choi YG; Choi EK; Kim YS J Vet Sci; 2019 Mar; 20(2):e8. PubMed ID: 30944531 [TBL] [Abstract][Full Text] [Related]
15. Reduced expression of the presynaptic co-chaperone cysteine string protein alpha (CSPα) does not exacerbate experimentally-induced ME7 prion disease. Davies MJ; Cooper M; Perry VH; O'Connor V Neurosci Lett; 2015 Mar; 589():138-43. PubMed ID: 25623034 [TBL] [Abstract][Full Text] [Related]
16. In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies. Jeffrey M; Goodsir CM; Bruce ME; McBride PA; Fraser JR Neuropathol Appl Neurobiol; 1997 Apr; 23(2):93-101. PubMed ID: 9160894 [TBL] [Abstract][Full Text] [Related]
17. Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated α-synuclein. Mougenot AL; Bencsik A; Nicot S; Vulin J; Morignat E; Verchère J; Bétemps D; Lakhdar L; Legastelois S; Baron TG J Neuropathol Exp Neurol; 2011 May; 70(5):377-85. PubMed ID: 21487306 [TBL] [Abstract][Full Text] [Related]
18. Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material. Murphy RG; Scanga JA; Powers BE; Pilon JL; Vercauteren KC; Nash PB; Smith GC; Belk KE J Anim Sci; 2009 May; 87(5):1787-93. PubMed ID: 19098230 [TBL] [Abstract][Full Text] [Related]
19. α-Synuclein deficiency and efferent nerve degeneration in the mouse cochlea: a possible cause of early-onset presbycusis. Park SN; Back SA; Choung YH; Kim HL; Akil O; Lustig LR; Park KH; Yeo SW Neurosci Res; 2011 Nov; 71(3):303-10. PubMed ID: 21840348 [TBL] [Abstract][Full Text] [Related]
20. Synaptic plasticity in the CA1 area of the hippocampus of scrapie-infected mice. Johnston AR; Fraser JR; Jeffrey M; MacLeod N Neurobiol Dis; 1998 Sep; 5(3):188-95. PubMed ID: 9848090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]